Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

679
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
679
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

790
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
790
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

4.6K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.6K
Neural Regulation of Blood Pressure01:18

Neural Regulation of Blood Pressure

7.7K
The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
7.7K
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

544
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
544
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

1.2K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolomic signatures of hepatic steatosis reveal heterogeneity in cardiometabolic risk and responses to lifestyle interventions in type 2 diabetes: a post hoc analysis.

Cardiovascular diabetology·2026
Same author

Neurovascular retinomics for predicting heart diseases.

Cardiovascular research·2026
Same author

Genome-wide analysis identifies susceptibility loci for heart failure and nonischemic cardiomyopathy subtype in the East Asian populations.

PLoS genetics·2025
Same author

Social Risk Profile and Cardiovascular-Kidney-Metabolic Syndrome in US Adults.

Journal of the American Heart Association·2024
Same author

Prognostic Value of a Multi-mRNA Signature for 1-Year All-Cause Death in Hospitalized Patients With Heart Failure With a Preserved Ejection Fraction.

Circulation. Heart failure·2024
Same author

Cognitive impairment in young and middle-aged patients with acute heart failure.

ESC heart failure·2024

Related Experiment Video

Updated: Feb 28, 2026

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
08:53

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Published on: June 6, 2025

1.9K

Intensive BP Control and Cognitive Function: A Randomized Clinical Trial.

Bin Wang1,2, Ying Sun1, Yan Li1

  • 1National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Center for Cardiovascular Diseases, Beijing, China (B.W., Y.S., Y. Li, Y.P., S.L., J.G., L. Zhang, L. Zhao, Jiangling Liu, H.Z., Jiamin Liu, Jing Li).

Hypertension (Dallas, Tex. : 1979)
|February 26, 2026
PubMed
Summary
This summary is machine-generated.

Intensive blood pressure control in Chinese adults did not negatively impact cognitive function. This study confirms the cognitive safety of targeting lower systolic blood pressure (<120 mm Hg) in hypertensive individuals.

Keywords:
blood pressurecognitionevidence gapincidencepublic health

More Related Videos

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

3.5K

Related Experiment Videos

Last Updated: Feb 28, 2026

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
08:53

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Published on: June 6, 2025

1.9K
Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

3.5K

Area of Science:

  • Cardiology
  • Neurology
  • Gerontology

Background:

  • Uncertainty exists regarding intensive blood pressure (BP) control effects on cognition in East Asians.
  • Hypertension management strategies require evaluation for cognitive impact.

Purpose of the Study:

  • To assess the effect of intensive systolic BP target (<120 mm Hg) versus standard target (<140 mm Hg) on global cognitive function.
  • To evaluate cognitive safety of intensive BP lowering in Chinese hypertensive adults.

Main Methods:

  • Secondary analysis of a randomized trial in 11,255 Chinese hypertensive adults with high cardiovascular risk.
  • Cognitive function assessed using Mini-Mental State Examination (MMSE) at baseline and after a median of 3.4 years.
  • Primary outcomes: change in MMSE score and probable dementia incidence.

Main Results:

  • No significant difference in mean MMSE score change between intensive (-0.54) and standard (-0.60) BP arms.
  • Results were consistent across sensitivity analyses and most subgroups.
  • Probable dementia incidence was too low for interpretation.

Conclusions:

  • Intensive systolic BP lowering to <120 mm Hg for 3 years did not adversely affect global cognitive function in Chinese hypertensive adults.
  • The findings affirm the cognitive safety of intensive BP control strategies.
  • Cognitive effects were consistent across various demographics and comorbidities.